• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Reducing the Risk of Comparator Sourcing

    Clinical Data Management

    Leveraging AI/ML Analytics for Better Clinical Development Decisions

    What is a Manufacturing Ecosystem and Why are They Growing?

    Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory

    Cellular Origins Launches Robotic Platform for Scalable Manufacture of Advanced Therapies

    Waters Corp. Acquires Light Scattering Company Wyatt Technology
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Manufacturing Complex Peptide APIs

    How CDMOs Can Leverage Contract Terms to Facilitate Payment

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Traceability & 2D Barcodes

    Complex in Complex – New Hopes for Better Drug Delivery in Topical Dosage Formulation

    Proactive Resource Group Offers DSCSA Services for Pharma Companies

    Catalent Adds New Cryogenic Capabilities at Japanese Facility

    TraceLink, PharmaLink Partner to Simplify DSCSA Compliance
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Manufacturing Complex Peptide APIs

    How CDMOs Can Leverage Contract Terms to Facilitate Payment

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility

    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA

    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    FDA 2023 Inspection Roadmap: Is “Readiness” in Your Annual Objectives?

    FDA Watch: Are You Suitably Staffed?

    FDA Watch: Is Your Supply Chain at Risk?

    FDA Watch: CDER to Launch Guidance Snapshot Pilot Program

    "3 Key Trends" with Paul Josephs
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Federal Equipment Company

    Almac Group

    INCOG BioPharma Services

    Syngene International Ltd.

    Lannett CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company

    Almac Group

    INCOG BioPharma Services

    Syngene International Ltd.

    Lannett CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Newsmakers: LSNE

    LSNE Expands Capabilities and QC Laboratory Space

    Newsmakers: LSNE
    Tim Wright, Editor05.08.18
    Lyophilization Services of New England (LSNE), a contract development and manufacturing organization (CDMO), recently unveiled a strategic plan to expand its quality control (QC) laboratory in Bedford, NH. The build-out calls for 37,000 square feet of new QC laboratory space and a centralized warehouse. Additionally, in conjunction with this expansion, LSNE will add approximately 45 new full-time positions. 

    The new, state-of-the-art laboratory will allow LSNE to increase its analytical and microbiology capabilities, to continue to support clients with their clinical and commercial products.
    The laboratory building, located on LSNE’s campus, will also house LSNE’S newly renovated centralized warehouse to support the company’s continued growth, including the offering of longer-term product storage for clients. The laboratory and warehouse are scheduled to be validated and operational during the second quarter of 2018. Recently, Contract Pharma had a chance to sit down with Jeff Clement, Director of Sales at LSNE and talk about the new lab.


    Contract Pharma: Why was the decision made to expand LSNE’s lab space?

    Jeff Clement:
    We listened to our clients. It’s been our company philosophy since the beginning. LSNE started out as a development and manufacturing company for lyophilized products. Then, as we grew, we got more and more into manufacturing, starting off with building our medical devices and diagnostics client base. Then we made the natural progression into sterile drug product manufacturing.

    Recently we’ve heard from a lot of our clients that have long lead times with some of their 3rd party quality control (QC) testing labs. We’ve always had a QC lab, but we thought it would be an opportune time to further support our clients and increase our analytical capabilities. Our laboratory is expanding in both personnel and equipment, while the actual size of it will grow about four-fold.

    The whole build out is comprised of QC lab space and a consolidated warehouse with large capacity for controlled storage requirements. We currently have four manufacturing sites.
    Each one of them has their own warehouse space. Part of the plan with this new 38,000 sq. ft. of space is to have that as a consolidated warehouse. Now each of the individual manufacturing sites have more of a ‘just-in-time’ warehouse. This allows us to be more nimble and responsive to the client’s schedules. Additionally, we now have more manufacturing supplies available to support our clients.

    CP: How does the new space help address customer needs?

    JC:
    All of our clients will have either testing to get their Active Pharmaceutical Ingredient (API) or the Bulk Drug Substance (BDS) released, as well as any in-process control testing, release testing and/or stability testing. Some of the bottlenecks we’ve seen occur is when our clients do not have a method assay established yet. That will slow down the process if they’re outsourcing that method to a third party laboratory and we’ve heard from our clients that the lead times on testing are getting longer and longer. Our QC team will be available for clients to develop assays or take an existing assay from the upstream manufacturer and further develop that or optimize it depending on the stage of the product.

    CP: How does the expansion complement other business capabilities and fold into other areas of expertise?

    JC:
    It’s really two-fold. The first part revolves around working with our existing client base. We’ve upgraded the instrumentation we have for high performance liquid chromatography (HPLC) and ultra-performance liquid chromatography (UPLC) testing and have increased personnel for a lot of standard physical chemistries like osmolality and pH testing. In fact, we recently have moved our QC function to a 7 Day, two shift operation. I also mentioned the scientists we’ve brought onboard to perform method development and we’re also getting into more complex process formulation and filling. A lot of these capabilities require specialized equipment. Recently we’ve added on gas chromatography (GC) equipment. We’re also in the process of getting GC upgraded so we can test the head space analysis on residual solvents. Recently we even added a headspace analyzer to determine oxygen content in the vials.
    In addition, we’ve had a number of clients developing nanoparticles or micro-sphere products. In response to this trend we offer a dedicated ISO-5 formulation suite. We also added a particle sizer and zeta potential testing to our capabilities in supporting this emerging area.

    So these are some of the things we’ve added on to further support our traditional existing clients. The additional equipment will help to support our newer types of complex processes.
    The second part of LSNE’s recent growth has to do with expanding into the existing analytical market. Traditionally, we’ve only supported the projects that we’re manufacturing. But right now we’re expanding our testing services for different dosage forms. Historically, LSNE has only worked with injectable drug products, but now we’re actually getting into stand-alone testing where we can test for not only APIs or intermediates, but we can also test for oral products, topicals, and other various routes of administration.

    Overall, LSNE is going through a broad expansion much beyond our traditional niche.

    CP: What have been some of the challenges encountered during this expansion process?

    JC:
    I think with the QC space the biggest challenge that we’ll have, especially where we’re outside of the parenteral marketplace, is dealing with the fact that we may not be well known in the oral dosage form and topicals market. We can perform that testing but I don’t think anybody would really be looking for us to do it. We’re going to have to get out into the market and let people know that we’re now offering these standalone testing capabilities. Especially where some companies might have a pain point of long lead times, now we’re willing to take on new business, where traditionally it’s only been a supporting arm of our business.

    We’ll be undergoing branding and marketing initiatives while training sales staff to sell the analytical services we now offer. Ultimately, it’s about letting our existing customers, as well as potential new customers, know that we can provide more now than just a manufacturing supporting role in the analytical services area.

    CP: What are some of trends in general driving the analytical and microbiological testing market?

    JC:
    I think a lot of the drive right now has to do with the through-put of business in general. A lot of the well-known analytical testing labs are overbooked so it presents an opportunity for a company like ours that does have excess QC capacity to expand our horizons a little bit and move further into the analytical testing space.

    CP: In addition to the new lab space and warehouse, are there any other expansion plans?

    JC:
    We are now working with our existing commercial clients to perform the labelling and meet all the new serialization requirements for them. In addition, we’ll also offer these capabilities as a stand-alone service. I think we’re a little bit ahead of the curve, by getting our commercial clients all set with the outside vendor, which has in-turn provided us with a lot of experience in this area. Now we’re taking that experience and working with a vendor to perform those services at LSNE. There’s potential for us to be doing labelling for a lot of our competitors which will be a great opportunity for us.

    Additionally, LSNE recently acquired PSC Biotech’s cGMP aseptic fill finish manufacturing facility located in Madison, WI. This acquisition allows LSNE to expand its manufacturing capabilities, add new service offerings and accommodate its customers’ project timing requirements. The new facility will be called LSNE-Madison.

    CP: What are some other areas LSNE will look to grow its business moving forward?

    JC:
    While we will always maintain our core manufacturing in supporting our clients, we’ll also continue to expand our horizons such as with the expanded QC capabilities and the serialization initiative. A couple other markets that we’re looking at now for potential growth is in the area of gene therapy and microbiome products. There is a lot of recent interest in these areas.

    Our company philosophy is we look to buy our own buildings so we can react quickly and respond to market demands. Right now we have a couple buildings we’re planning further expansion into on our Bedford, NH campus. One of these areas will focus on gene therapy and microbiome products. For now we’re calling it “flex-space” where we will start with some development of these microbiome live cell products that is completely outside our standard GMP manufacturing process in completely separate facilities. Our first projects will be non-GMP R&D work. But what we have going for us is 21 years of lyophilization experience that will help us develop lyophilization cycles for the client. One of our sites has a lot of bulk lyophilization capabilities, and while this work would not be performed at that site, the experience we have in bulk lyophilization is readily transferable with the microbiome products.

    This is one other way we’re getting our name out there to see how the market is looking at us. We’ll see how it goes and ultimately decide if we want to make that leap in investment into getting some GMP manufacturing for microbiome and gene therapy products, in the near future. 
    Related Searches
    • GMP
    • Aseptic
    • contract pharma
    • equipment
    Suggested For You
    Coriolis Pharma Coriolis Pharma
    Alcami Alcami
    Altasciences Altasciences
    Vetio Animal Health Vetio Animal Health
    Interphex Exhibitor List Interphex Exhibitor List
    Back to the (BIO)Future! Back to the (BIO)Future!
    Rising CMO Business Fortunes Rising CMO Business Fortunes
    The Beginning of a New Era? The Beginning of a New Era?
    LSNE Acquires PSC Biotech’s Parenteral Mfg. Facility LSNE Acquires PSC Biotech’s Parenteral Mfg. Facility
    Avema to Showcase Range of Services Avema to Showcase Range of Services
    Contract Pharma Welcomes New Associate Editor Contract Pharma Welcomes New Associate Editor
    LSNE Expands Capabilities and QC Laboratory Space LSNE Expands Capabilities and QC Laboratory Space
    Idifarma Expands High Potent Capabilities Idifarma Expands High Potent Capabilities
    Integrated Early-Stage Drug Development and Manufacturing Integrated Early-Stage Drug Development and Manufacturing
    FDCs on the Rise FDCs on the Rise

    Related Buyers Guide Companies

    • Coriolis Pharma

      Coriolis Pharma

      ...
      Bettina von Klitzing-Stu00fcckle 07.01.21

    • Alcami

      Alcami

      ...
      Kristine LeBlanc, Associate Marketing Director 12.01.20

    • Altasciences

      Altasciences

      ...
      Ben Reed, VP, Manufacturing 10.28.19


    • Vetio Animal Health

      Vetio Animal Health

      ...
      John Kane, CEO 10.24.19

    • Lyophilization
      Interphex Exhibitor List

      Interphex Exhibitor List

      ...
      03.25.19

    Loading, Please Wait..
    Trending
    • Aurigene Expands Biologics CDMO Capacity
    • Astellas To Transfer Manufacturing Plant To Delpharm
    • Catalent Adds New Cryogenic Capabilities At Japanese Facility
    • Thermo Fisher Expands Steriles Facility In Asia-Pacific Region
    • Lifecore Biomedical Enters Into $150M New Financing Deal
    Breaking News
    • Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    • JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    • Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    • Cellular Origins Launches Robotic Platform for Scalable Manufacture of Advanced Therapies
    • Waters Corp. Acquires Light Scattering Company Wyatt Technology
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • New Modalities Hog the Limelight
    • Cell and Gene Therapy is Coming of Age
    • Demand Surges for Cell and Gene Therapy Contract Manufacturing
    • Embracing a New Reality
    • Japan: A Unique Opportunity for Regenerative Medicines and Cell & Gene Therapies
    • Single-Use Technologies Enable Biologic Scaling
    • Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    • FTEs in Drug Discovery
    • Digital Transformation in Pharma
    • What is a Manufacturing Ecosystem and Why are They Growing?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Coatings World

    Latest Breaking News From Coatings World

    Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
    BCF Calls for Greater Urgency on REACH Impasse
    MNYCA Hosts Afternoon Baseball Event
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    Capitainer Releases to Market its Fully Automated Sample Handler
    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    Charles River, Wheeler Bio Partner to Operate RightSource Laboratory
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Stetson Introduces Men’s Grooming Portfolio
    Two Executives Depart from Unilever Amid CEO Transition
    L’Oréal Paris Welcomes Thuso Mbedu as Brand Ambassador
    Happi

    Latest Breaking News From Happi

    Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
    Unilever Ventures’ Backs Selva Ventures in $34 Million Fund for Early-Stage CPG Brands
    Two Executives Depart from Unilever Amid CEO Transition
    Ink World

    Latest Breaking News From Ink World

    ACTEGA, Makro Labelling to Advance Signite Technology
    BCF Requests Greater Urgency on REACH Impasse
    Updated Method Published for Entire BASF Product Portfolio
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ACTEGA teams with Makro Labelling to advance Signite technology
    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mann+Hummel Names President Air Filtration Americas
    KNH Launches Eco-Friendly Menstrual Pads
    Niine Introduces India's First PLA-Based Sanitary Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Enrollment Completed in Anika Therapeutics' Hyalofast Study
    Exactech Releases Next-Gen GPS Shoulder
    Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Presents Path to Accelerate Revenue Growth
    STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
    Graphene Flagship to Join Euro Nano Forum 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login